Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) Stock Competitors & Peer Comparison
See PHH's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PHH and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PHH | $0.39 | -0.08% | 10M | -0.53 | -$0.72 | N/A |
| PG | $144.55 | +0.20% | 343.6B | 20.83 | $6.94 | +2.97% |
| UL | $62.09 | -0.94% | 133.8B | 20.42 | $3.04 | +3.57% |
| CL | $91.95 | -1.05% | 73.6B | 24.52 | $3.75 | +2.29% |
| KVUE | $19.20 | +0.00% | 36.8B | 16.26 | $1.18 | +4.33% |
| KMB | $110.39 | -0.28% | 36.6B | 14.82 | $7.45 | +4.60% |
| EL | $86.10 | -1.40% | 31.1B | 38.95 | $2.21 | +1.62% |
| CHD | $101.30 | -0.02% | 24B | 28.46 | $3.56 | +1.21% |
| CLX | $105.70 | -0.79% | 12.8B | 19.08 | $5.54 | +4.72% |
| REYN | $26.25 | -0.23% | 5.5B | 15.35 | $1.71 | +3.51% |
Stock Comparison
The Procter & Gamble Company (NYSE: PG)
PHH vs PG Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, PG has a market cap of 343.6B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while PG trades at $144.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas PG's P/E ratio is 20.83. In terms of profitability, PHH's ROE is +0.38%, compared to PG's ROE of +0.30%. Regarding short-term risk, PHH is more volatile compared to PG. This indicates higher risk in terms of short-term price fluctuations for PHH.Check PG's competition here
Unilever PLC (NYSE: UL)
PHH vs UL Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, UL has a market cap of 133.8B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while UL trades at $62.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas UL's P/E ratio is 20.42. In terms of profitability, PHH's ROE is +0.38%, compared to UL's ROE of +0.36%. Regarding short-term risk, PHH is more volatile compared to UL. This indicates higher risk in terms of short-term price fluctuations for PHH.Check UL's competition here
Colgate-Palmolive Company (NYSE: CL)
PHH vs CL Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, CL has a market cap of 73.6B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while CL trades at $91.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas CL's P/E ratio is 24.52. In terms of profitability, PHH's ROE is +0.38%, compared to CL's ROE of +6.31%. Regarding short-term risk, PHH is more volatile compared to CL. This indicates higher risk in terms of short-term price fluctuations for PHH.Check CL's competition here
Kenvue Inc. (NYSE: KVUE)
PHH vs KVUE Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, KVUE has a market cap of 36.8B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while KVUE trades at $19.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas KVUE's P/E ratio is 16.26. In terms of profitability, PHH's ROE is +0.38%, compared to KVUE's ROE of +0.16%. Regarding short-term risk, PHH is more volatile compared to KVUE. This indicates higher risk in terms of short-term price fluctuations for PHH.Check KVUE's competition here
Kimberly-Clark Corporation (NASDAQ: KMB)
PHH vs KMB Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, KMB has a market cap of 36.6B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while KMB trades at $110.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas KMB's P/E ratio is 14.82. In terms of profitability, PHH's ROE is +0.38%, compared to KMB's ROE of +1.23%. Regarding short-term risk, PHH is more volatile compared to KMB. This indicates higher risk in terms of short-term price fluctuations for PHH.Check KMB's competition here
The Estée Lauder Companies Inc. (NYSE: EL)
PHH vs EL Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, EL has a market cap of 31.1B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while EL trades at $86.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas EL's P/E ratio is 38.95. In terms of profitability, PHH's ROE is +0.38%, compared to EL's ROE of -0.06%. Regarding short-term risk, PHH is more volatile compared to EL. This indicates higher risk in terms of short-term price fluctuations for PHH.Check EL's competition here
Church & Dwight Co., Inc. (NYSE: CHD)
PHH vs CHD Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, CHD has a market cap of 24B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while CHD trades at $101.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas CHD's P/E ratio is 28.46. In terms of profitability, PHH's ROE is +0.38%, compared to CHD's ROE of +0.18%. Regarding short-term risk, PHH is more volatile compared to CHD. This indicates higher risk in terms of short-term price fluctuations for PHH.Check CHD's competition here
The Clorox Company (NYSE: CLX)
PHH vs CLX Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, CLX has a market cap of 12.8B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while CLX trades at $105.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas CLX's P/E ratio is 19.08. In terms of profitability, PHH's ROE is +0.38%, compared to CLX's ROE of -18.94%. Regarding short-term risk, PHH is more volatile compared to CLX. This indicates higher risk in terms of short-term price fluctuations for PHH.Check CLX's competition here
Reynolds Consumer Products Inc. (NASDAQ: REYN)
PHH vs REYN Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, REYN has a market cap of 5.5B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while REYN trades at $26.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas REYN's P/E ratio is 15.35. In terms of profitability, PHH's ROE is +0.38%, compared to REYN's ROE of +0.15%. Regarding short-term risk, PHH is more volatile compared to REYN. This indicates higher risk in terms of short-term price fluctuations for PHH.Check REYN's competition here
e.l.f. Beauty, Inc. (NYSE: ELF)
PHH vs ELF Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, ELF has a market cap of 5.4B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while ELF trades at $91.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas ELF's P/E ratio is 22.93. In terms of profitability, PHH's ROE is +0.38%, compared to ELF's ROE of +0.05%. Regarding short-term risk, PHH is more volatile compared to ELF. This indicates higher risk in terms of short-term price fluctuations for PHH.Check ELF's competition here
Natura &Co Holding S.A. (NYSE: NTCO)
PHH vs NTCO Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas NTCO's P/E ratio is -11.37. In terms of profitability, PHH's ROE is +0.38%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, PHH is more volatile compared to NTCO. This indicates higher risk in terms of short-term price fluctuations for PHH.Check NTCO's competition here
Inter Parfums, Inc. (NASDAQ: IPAR)
PHH vs IPAR Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, IPAR has a market cap of 3.7B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while IPAR trades at $114.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas IPAR's P/E ratio is 21.92. In terms of profitability, PHH's ROE is +0.38%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, PHH is more volatile compared to IPAR. This indicates higher risk in terms of short-term price fluctuations for PHH.Check IPAR's competition here
Central Garden & Pet Company (NASDAQ: CENT)
PHH vs CENT Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, CENT has a market cap of 2.7B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while CENT trades at $43.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas CENT's P/E ratio is 14.82. In terms of profitability, PHH's ROE is +0.38%, compared to CENT's ROE of +0.10%. Regarding short-term risk, PHH is more volatile compared to CENT. This indicates higher risk in terms of short-term price fluctuations for PHH.Check CENT's competition here
Newell Brands Inc. (NASDAQ: NWL)
PHH vs NWL Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, NWL has a market cap of 2.7B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while NWL trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas NWL's P/E ratio is 11.56. In terms of profitability, PHH's ROE is +0.38%, compared to NWL's ROE of -0.09%. Regarding short-term risk, PHH is more volatile compared to NWL. This indicates higher risk in terms of short-term price fluctuations for PHH.Check NWL's competition here
Coty Inc. (NYSE: COTY)
PHH vs COTY Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, COTY has a market cap of 2.5B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while COTY trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas COTY's P/E ratio is 15.81. In terms of profitability, PHH's ROE is +0.38%, compared to COTY's ROE of -0.15%. Regarding short-term risk, PHH is more volatile compared to COTY. This indicates higher risk in terms of short-term price fluctuations for PHH.Check COTY's competition here
Spectrum Brands Holdings, Inc. (NYSE: SPB)
PHH vs SPB Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, SPB has a market cap of 2.1B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while SPB trades at $89.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas SPB's P/E ratio is 13.83. In terms of profitability, PHH's ROE is +0.38%, compared to SPB's ROE of +0.04%. Regarding short-term risk, PHH is more volatile compared to SPB. This indicates higher risk in terms of short-term price fluctuations for PHH.Check SPB's competition here
Edgewell Personal Care Company (NYSE: EPC)
PHH vs EPC Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, EPC has a market cap of 1.3B. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while EPC trades at $28.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas EPC's P/E ratio is 15.45. In terms of profitability, PHH's ROE is +0.38%, compared to EPC's ROE of -0.06%. Regarding short-term risk, PHH is more volatile compared to EPC. This indicates higher risk in terms of short-term price fluctuations for PHH.Check EPC's competition here
Oddity Tech Ltd. (NASDAQ: ODD)
PHH vs ODD Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, ODD has a market cap of 747.2M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while ODD trades at $13.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas ODD's P/E ratio is 10.08. In terms of profitability, PHH's ROE is +0.38%, compared to ODD's ROE of +0.14%. Regarding short-term risk, PHH is more volatile compared to ODD. This indicates higher risk in terms of short-term price fluctuations for PHH.Check ODD's competition here
Helen of Troy Limited (NASDAQ: HELE)
PHH vs HELE Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, HELE has a market cap of 703.9M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while HELE trades at $30.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas HELE's P/E ratio is 9.16. In terms of profitability, PHH's ROE is +0.38%, compared to HELE's ROE of -0.48%. Regarding short-term risk, PHH is more volatile compared to HELE. This indicates higher risk in terms of short-term price fluctuations for PHH.Check HELE's competition here
The Honest Company, Inc. (NASDAQ: HNST)
PHH vs HNST Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, HNST has a market cap of 532.8M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while HNST trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas HNST's P/E ratio is 75.87. In terms of profitability, PHH's ROE is +0.38%, compared to HNST's ROE of -0.07%. Regarding short-term risk, PHH is more volatile compared to HNST. This indicates higher risk in terms of short-term price fluctuations for PHH.Check HNST's competition here
Magnera Corp (NYSE: MAGN)
PHH vs MAGN Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, MAGN has a market cap of 444.3M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while MAGN trades at $12.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas MAGN's P/E ratio is -6.04. In terms of profitability, PHH's ROE is +0.38%, compared to MAGN's ROE of -0.11%. Regarding short-term risk, PHH is more volatile compared to MAGN. This indicates higher risk in terms of short-term price fluctuations for PHH.Check MAGN's competition here
European Wax Center, Inc. (NASDAQ: EWCZ)
PHH vs EWCZ Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, PHH's ROE is +0.38%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, PHH is more volatile compared to EWCZ. This indicates higher risk in terms of short-term price fluctuations for PHH.Check EWCZ's competition here
Yatsen Holding Limited (NYSE: YSG)
PHH vs YSG Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, YSG has a market cap of 316.9M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while YSG trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas YSG's P/E ratio is -26.45. In terms of profitability, PHH's ROE is +0.38%, compared to YSG's ROE of -0.05%. Regarding short-term risk, PHH is more volatile compared to YSG. This indicates higher risk in terms of short-term price fluctuations for PHH.Check YSG's competition here
USANA Health Sciences, Inc. (NYSE: USNA)
PHH vs USNA Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, USNA has a market cap of 246.5M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while USNA trades at $13.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas USNA's P/E ratio is 13.48. In terms of profitability, PHH's ROE is +0.38%, compared to USNA's ROE of -0.04%. Regarding short-term risk, PHH is more volatile compared to USNA. This indicates higher risk in terms of short-term price fluctuations for PHH.Check USNA's competition here
Nu Skin Enterprises, Inc. (NYSE: NUS)
PHH vs NUS Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, NUS has a market cap of 233.3M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while NUS trades at $4.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas NUS's P/E ratio is 4.00. In terms of profitability, PHH's ROE is +0.38%, compared to NUS's ROE of -0.29%. Regarding short-term risk, PHH is more volatile compared to NUS. This indicates higher risk in terms of short-term price fluctuations for PHH.Check NUS's competition here
Acme United Corporation (AMEX: ACU)
PHH vs ACU Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, ACU has a market cap of 231.8M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while ACU trades at $60.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas ACU's P/E ratio is 26.22. In terms of profitability, PHH's ROE is +0.38%, compared to ACU's ROE of +0.08%. Regarding short-term risk, PHH is more volatile compared to ACU. This indicates higher risk in terms of short-term price fluctuations for PHH.Check ACU's competition here
Pitanium Limited (NASDAQ: PTNM)
PHH vs PTNM Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas PTNM's P/E ratio is 346.33. In terms of profitability, PHH's ROE is +0.38%, compared to PTNM's ROE of -0.99%. Regarding short-term risk, PHH is more volatile compared to PTNM. This indicates higher risk in terms of short-term price fluctuations for PHH.Check PTNM's competition here
Waldencast plc (NASDAQ: WALD)
PHH vs WALD Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, WALD has a market cap of 159.6M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while WALD trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas WALD's P/E ratio is -2.25. In terms of profitability, PHH's ROE is +0.38%, compared to WALD's ROE of -0.48%. Regarding short-term risk, PHH is more volatile compared to WALD. This indicates higher risk in terms of short-term price fluctuations for PHH.Check WALD's competition here
Waldencast plc (NASDAQ: WALDW)
PHH vs WALDW Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, WALDW has a market cap of 149.1M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while WALDW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas WALDW's P/E ratio is -0.05. In terms of profitability, PHH's ROE is +0.38%, compared to WALDW's ROE of -0.48%. Regarding short-term risk, PHH is less volatile compared to WALDW. This indicates lower risk in terms of short-term price fluctuations for PHH.Check WALDW's competition here
Solesence, Inc. Common Stock (NASDAQ: SLSN)
PHH vs SLSN Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, SLSN has a market cap of 73.5M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while SLSN trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas SLSN's P/E ratio is 84.55. In terms of profitability, PHH's ROE is +0.38%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, PHH is more volatile compared to SLSN. This indicates higher risk in terms of short-term price fluctuations for PHH.Check SLSN's competition here
Upexi, Inc. (NASDAQ: UPXI)
PHH vs UPXI Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, UPXI has a market cap of 54.9M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while UPXI trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas UPXI's P/E ratio is -0.17. In terms of profitability, PHH's ROE is +0.38%, compared to UPXI's ROE of -3.07%. Regarding short-term risk, PHH is more volatile compared to UPXI. This indicates higher risk in terms of short-term price fluctuations for PHH.Check UPXI's competition here
Grove Collaborative Holdings, Inc. (NYSE: GROV)
PHH vs GROV Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, GROV has a market cap of 43.7M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while GROV trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas GROV's P/E ratio is -4.00. In terms of profitability, PHH's ROE is +0.38%, compared to GROV's ROE of -0.83%. Regarding short-term risk, PHH is more volatile compared to GROV. This indicates higher risk in terms of short-term price fluctuations for PHH.Check GROV's competition here
Axil Brands, Inc. (AMEX: AXIL)
PHH vs AXIL Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, AXIL has a market cap of 41.5M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while AXIL trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas AXIL's P/E ratio is 50.71. In terms of profitability, PHH's ROE is +0.38%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, PHH is more volatile compared to AXIL. This indicates higher risk in terms of short-term price fluctuations for PHH.Check AXIL's competition here
United-Guardian, Inc. (NASDAQ: UG)
PHH vs UG Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, UG has a market cap of 32.8M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while UG trades at $7.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas UG's P/E ratio is 13.71. In terms of profitability, PHH's ROE is +0.38%, compared to UG's ROE of +0.22%. Regarding short-term risk, PHH is more volatile compared to UG. This indicates higher risk in terms of short-term price fluctuations for PHH.Check UG's competition here
Big Tree Cloud Holdings Limited (NASDAQ: DSY)
PHH vs DSY Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, DSY has a market cap of 20.2M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while DSY trades at $4.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas DSY's P/E ratio is -0.47. In terms of profitability, PHH's ROE is +0.38%, compared to DSY's ROE of +14.77%. Regarding short-term risk, PHH is more volatile compared to DSY. This indicates higher risk in terms of short-term price fluctuations for PHH.Check DSY's competition here
Mannatech, Incorporated (NASDAQ: MTEX)
PHH vs MTEX Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, MTEX has a market cap of 12M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while MTEX trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas MTEX's P/E ratio is -0.93. In terms of profitability, PHH's ROE is +0.38%, compared to MTEX's ROE of +3.37%. Regarding short-term risk, PHH is less volatile compared to MTEX. This indicates lower risk in terms of short-term price fluctuations for PHH.Check MTEX's competition here
Bruush Oral Care Inc. (NASDAQ: BRSH)
PHH vs BRSH Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas BRSH's P/E ratio is -0.01. In terms of profitability, PHH's ROE is +0.38%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, PHH is less volatile compared to BRSH. This indicates lower risk in terms of short-term price fluctuations for PHH.Check BRSH's competition here
Tantech Holdings Ltd (NASDAQ: TANH)
PHH vs TANH Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, TANH has a market cap of 5.7M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while TANH trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas TANH's P/E ratio is 0.04. In terms of profitability, PHH's ROE is +0.38%, compared to TANH's ROE of -0.25%. Regarding short-term risk, PHH is less volatile compared to TANH. This indicates lower risk in terms of short-term price fluctuations for PHH.Check TANH's competition here
Park Ha Biological Technology Co., Ltd. Ordinary Shares (NASDAQ: BYAH)
PHH vs BYAH Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, BYAH has a market cap of 2.5M. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while BYAH trades at $3.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas BYAH's P/E ratio is N/A. In terms of profitability, PHH's ROE is +0.38%, compared to BYAH's ROE of -1.74%. Regarding short-term risk, PHH is less volatile compared to BYAH. This indicates lower risk in terms of short-term price fluctuations for PHH.Check BYAH's competition here
Bruush Oral Care Inc. (NASDAQ: BRSHW)
PHH vs BRSHW Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas BRSHW's P/E ratio is N/A. In terms of profitability, PHH's ROE is +0.38%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, PHH is less volatile compared to BRSHW. This indicates lower risk in terms of short-term price fluctuations for PHH.Check BRSHW's competition here
Grove Collaborative Holdings, Inc. (NYSE: GROV-WT)
PHH vs GROV-WT Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, PHH's ROE is +0.38%, compared to GROV-WT's ROE of -0.83%. Regarding short-term risk, PHH is more volatile compared to GROV-WT. This indicates higher risk in terms of short-term price fluctuations for PHH.Check GROV-WT's competition here
Elizabeth Arden, Inc. (NASDAQ: RDEN)
PHH vs RDEN Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas RDEN's P/E ratio is -5.68. In terms of profitability, PHH's ROE is +0.38%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, PHH is more volatile compared to RDEN. This indicates higher risk in terms of short-term price fluctuations for PHH.Check RDEN's competition here
Summer Infant, Inc. (NASDAQ: SUMR)
PHH vs SUMR Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas SUMR's P/E ratio is -3.66. In terms of profitability, PHH's ROE is +0.38%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, PHH is more volatile compared to SUMR. This indicates higher risk in terms of short-term price fluctuations for PHH.Check SUMR's competition here
Revlon, Inc. (NYSE: REV)
PHH vs REV Comparison August 2026
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) plays a significant role within the Consumer Defensive sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PHH stands at 10M. In comparison, REV has a market cap of 0. Regarding current trading prices, PHH is priced at $0.39 on the NASDAQ, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PHH currently has a P/E ratio of -0.53, whereas REV's P/E ratio is -1.19. In terms of profitability, PHH's ROE is +0.38%, compared to REV's ROE of +0.89%. Regarding short-term risk, PHH is more volatile compared to REV. This indicates higher risk in terms of short-term price fluctuations for PHH.Check REV's competition here